TABLE 1.
VSV RNAa | Peak no. | Peak range (nt)b | Gene locationc | Peak size (nt) | Fold enrichmentd | Putative m6A site(s)e |
---|---|---|---|---|---|---|
Genome | 1 | 898–1047 | N | 149 | 2.57 | AAACC |
2 | 1944–2143 | P | 199 | 5.26 | GAACA, AGACA | |
3 | 2891–3040 | M | 149 | 20.7 | GAACA, GAACA | |
4 | 3389–3588 | G | 199 | 6.16 | GAACA, GAACA, AAACA, GAACT | |
5 | 3838–4036 | G | 198 | 22.56 | AGACC, AAACC | |
6 | 7426–7475 | L | 49 | 2.10 | NA | |
Antigenome | 1 | 1–449 | N | 448 | 11.99 | AAACT, AGACA, AAACT, GAACT, AGACA |
2 | 499–548 | N | 49 | 3.51 | NA | |
3 | 599–698 | N | 99 | 2.39 | GAACA, GAACA | |
4 | 898–997 | N | 99 | 2.84 | AGACT, AGACA | |
5 | 1147–1246 | N | 99 | 2.55 | AAACC | |
6 | 1396–1894 | P | 498 | 43.8 | AAACC, GAACA, GGACT, GGACT, GAACT | |
7 | 1944–1993 | P | 49 | 6.79 | AGACC, AAACA | |
8 | 2742–2890 | M | 148 | 4.50 | AAACA, AGACC | |
9 | 3389–3488 | G | 99 | 3.64 | NA | |
10 | 3688–4036 | G | 348 | 10.26 | AGACC, AGACT, GAACC, AGACA, GAACC | |
11 | 4685–4784 | L | 99 | 3.62 | GAACT, GGACT | |
12 | 4884–4933 | L | 49 | 2.57 | NA | |
13 | 5582–5681 | L | 99 | 3.13 | GGACT | |
14 | 6678–6727 | L | 49 | 2.46 | GAACA | |
15 | 7575–7624 | L | 49 | 7.38 | GGACT | |
16 | 8323–8471 | L | 148 | 11.02 | GAACC, AAACC, AGACC, GAACC | |
17 | 8771–8820 | L | 49 | 2.02 | NA | |
18 | 8970–9119 | L | 149 | 2.08 | AAACC, AGACT | |
19 | 10615–10664 | L | 49 | 4.80 | AAACT | |
20 | 10764–10863 | L | 99 | 10.25 | GGACC | |
21 | 10914–11062 | L | 148 | 2.71 | AGACC | |
mRNAs | 1 | 51–249 | N | 198 | 5.18 | AGACA, AAACT, GAACT, AGACA |
2 | 1346–1445 | gs, ge, and ig | 99 | 5.73 | GGACT, GAACT | |
3 | 1496–1595 | P | 99 | 2.01 | GAACA, GGACT | |
4 | 1645–1844 | P | 199 | 6.62 | AAACC | |
5 | 4685–4784 | G, gs, ge, ig, L | 99 | 12.64 | GAACT, GGACT | |
6 | 8372–8471 | L | 99 | 2.06 | GAACC, AAACC, AGACC, GAACC |
Genome and antigenome were extracted from highly purified virions grown in A549 cells. VSV mRNAs were extracted from VSV-infected A549 cells and purified by poly(A) bead.
Nucleotide sequence position with reference to the VSV Indiana strain (GenBank accession no. J02428). Nucleotide ranges are indicated.
The VSV genes and regulatory elements are covered by m6A peaks. These regions may contain m6A sites. VSV gene start, gene end, and intergenic sequence are indicated by gs, ge, and ig, respectively.
Log2 enrichment of the m6A peaks identified in the VSV genome, antigenome, and mRNAs.
Putative m6A sites are identified based on searching for the presence of the m6A motif Pu [G > A]m6AC[A/C/U] (Pu represents purine) in the peak ranges. NA indicates no known m6A motifs are found in this region.